150 related articles for article (PubMed ID: 12264128)
1. Lactation pattern in Egyptian women using the Progestasert system.
Badraoui MH; Askalani H; Mahrous I; Serour G; Hefnawi F
Contracept Deliv Syst; 1982 Jan; 3(1):53-60. PubMed ID: 12264128
[TBL] [Abstract][Full Text] [Related]
2. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
Custo GM; Cosmi EV
Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
[TBL] [Abstract][Full Text] [Related]
3. Serum prolactin levels in lactating women using progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
[TBL] [Abstract][Full Text] [Related]
4. Corpus luteum function in lactating women using the Progestasert system.
Abdalla MI; Ibrahim II; Osman MI; Badraoui MH; Askalani H
Contracept Deliv Syst; 1981 Apr; 2(1):127-32. PubMed ID: 12336864
[TBL] [Abstract][Full Text] [Related]
5. Serum cortisol level in lactating women using Progestasert system.
Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
[TBL] [Abstract][Full Text] [Related]
6. Serum-prolactin levels in lactating women using the Progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Contracept Deliv Syst; 1981 Apr; 2(1):121-6. PubMed ID: 12336863
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function in lactating women using the Progestasert system.
Ibrahim II; Abdalla MI; Badraoui MH; Abdelaal AE
Contracept Deliv Syst; 1981 Apr; 2(1):139-44. PubMed ID: 12336866
[TBL] [Abstract][Full Text] [Related]
8. Serum cortisol level in lactating women using the Progestasert system.
Askalani H; Badraoui MH; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Contracept Deliv Syst; 1981 Apr; 2(1):133-8. PubMed ID: 12336865
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine devices containing progesterone.
Murad F
Drug Ther (NY); 1977 May; 7(5):119-21. PubMed ID: 12277687
[TBL] [Abstract][Full Text] [Related]
10. Comparison between two IUDs: Progestasert and CuT 200.
Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
[TBL] [Abstract][Full Text] [Related]
11. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
12. Selecting patients and inserting the Progestasert.
Soderstrom RM
Am J Gynecol Health; 1989; 3(3-S):17-8. PubMed ID: 12284993
[TBL] [Abstract][Full Text] [Related]
13. A clinical study comparing the performance of three IUCDs (Multiload Copper 250, Copper T 200, and Lippes Loop C).
Fakhr MM; Fakhr DM; Hassan AA; Nasser NM
Popul Sci; 1988; 8():39-53. PubMed ID: 12316112
[TBL] [Abstract][Full Text] [Related]
14. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
Abdulla SH
J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
[TBL] [Abstract][Full Text] [Related]
15. Corpus luteum function in medicated and non-medicated IUD users.
Abdalla MI; Ibrahim II; Osman MI; Bayad MA; Hafez ES
Contracept Deliv Syst; 1983 Jul; 4(3):163-7. PubMed ID: 12265358
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of U-coil progesterone releasing device versus inert U-coil IUD.
Serour GI; Hamza A; El Sheikha Z; Hefnawi FI
Popul Sci; 1982; (3):121-35. PubMed ID: 12266213
[TBL] [Abstract][Full Text] [Related]
17. The early post-partum insertion of the nylon ring.
Ragab MI; Mahran M; Fadel HE
Ain Shams Med J; 1970 Jan; 21(1):25-7. PubMed ID: 12305245
[TBL] [Abstract][Full Text] [Related]
18. [The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD
Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
[TBL] [Abstract][Full Text] [Related]
19. Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.
Kurz KH
Contracept Deliv Syst; 1981 Jan; 2(1):21-9. PubMed ID: 12278585
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with Progestasert beyond one year of use.
Wan LS
Contracept Deliv Syst; 1981 Jul; 2(3):243-8. PubMed ID: 12278911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
